Pfs25-Pfs230 malaria vaccine (MVI)

N/A

Report date: 2022/01/14 13:23:58

Base Information

Drug NamePfs25-Pfs230 malaria vaccine (MVI)
Drug Alias NamePFS25 VLP & Pfs230 VLPPfs25/Alhydrogel and Pfs230D1M-EPA/AlhydrogelPfs25M-EPA/AS01 and Pfs230D1M-EPA/AS01
ClassificationVaccines > Application > Prophylactic vaccine
Mechanisms of ActionImmunostimulants
TargetsNot applicable
Therapy Area/IndicationsMalaria
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesMalaria Vaccine InitiativeBurnet Institute
China Registration ClassN/A

Develop Information

Active CompaniesBurnet InstituteMalaria Vaccine InitiativeNational Institute Of Allergy And Infectious Diseases (Niaid)
Inactive CompaniesN/A
Active IndicationsMalaria
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A